Mild or Moderate Covid-19.
作者信息
Gandhi Rajesh T, Lynch John B, Del Rio Carlos
机构信息
From Massachusetts General Hospital and Harvard Medical School, Boston (R.T.G.); the Department of Medicine, Division of Allergy and Infectious Diseases, University of Washington School of Medicine, Seattle (J.B.L.); and the Department of Medicine, Division of Infectious Diseases, Emory University School of Medicine, and Grady Health System, Atlanta (C.R.).
出版信息
N Engl J Med. 2020 Oct 29;383(18):1757-1766. doi: 10.1056/NEJMcp2009249. Epub 2020 Apr 24.
PMID:32329974
Abstract
摘要
相似文献
1
Mild or Moderate Covid-19.轻度或中度新冠病毒感染
N Engl J Med. 2020 Oct 29;383(18):1757-1766. doi: 10.1056/NEJMcp2009249. Epub 2020 Apr 24.
2
Environmental virus surveillance in the isolation ward of COVID-19.新型冠状病毒肺炎隔离病房的环境病毒监测
J Hosp Infect. 2020 Jun;105(2):373-374. doi: 10.1016/j.jhin.2020.04.020. Epub 2020 Apr 15.
3
Preparedness for COVID-19 infection prevention in Korea: a single-centre experience.韩国预防新型冠状病毒肺炎感染的准备工作：单中心经验
J Hosp Infect. 2020 Jun;105(2):370-372. doi: 10.1016/j.jhin.2020.04.018. Epub 2020 Apr 14.
4
Audio Interview: Diagnosis and Early Treatment of Covid-19.音频访谈：新型冠状病毒肺炎的诊断与早期治疗
N Engl J Med. 2020 Jun 4;382(23):e103. doi: 10.1056/NEJMe2021023.
5
Do we know when to end isolation of persons affected with COVID-19?我们知道何时结束对新冠病毒感染者的隔离吗？
Eur J Intern Med. 2020 Jul;77:144-146. doi: 10.1016/j.ejim.2020.04.063. Epub 2020 May 3.
6
Coronavirus: origins, signs, prevention and management of patients.冠状病毒：起源、症状、患者的预防与管理
Br J Nurs. 2020 Apr 9;29(7):399-402. doi: 10.12968/bjon.2020.29.7.399.
7
[A few hints to face Covid-19 pandemic in Italy].[应对意大利新冠疫情的几点提示]
Epidemiol Prev. 2020 Jul-Aug;44(4):201. doi: 10.19191/EP20.4.P201.049.
8
Beyond the assistance: additional exposure situations to COVID-19 for healthcare workers.援助之外：医护人员面临的新冠病毒额外暴露情况
J Hosp Infect. 2020 Jun;105(2):353. doi: 10.1016/j.jhin.2020.03.033. Epub 2020 Mar 31.
9
COVID-19: before stopping specific infection prevention and control measures, be sure to exclude the diagnosis.新冠病毒病：在停止特定感染预防与控制措施之前，务必排除诊断。
J Hosp Infect. 2020 Jun;105(2):375-376. doi: 10.1016/j.jhin.2020.04.021. Epub 2020 Apr 25.
10
Testing Armed Forces recruits for COVID-19.对武装部队新兵进行新冠病毒检测。
Tidsskr Nor Laegeforen. 2020 May 21;140(10). doi: 10.4045/tidsskr.20.0384. Print 2020 Jun 30.
引用本文的文献
1
Exploring the Association Between COVID-19 and Avascular Necrosis: A Systematic Review.探索2019冠状病毒病与缺血性坏死之间的关联：一项系统综述。
Cureus. 2025 Aug 4;17(8):e89318. doi: 10.7759/cureus.89318. eCollection 2025 Aug.
2
Sex-specific vulnerabilities in early human neurodevelopment following SARS-CoV-2-induced maternal immune activation.新冠病毒诱导的母体免疫激活后早期人类神经发育中的性别特异性脆弱性
Eur Child Adolesc Psychiatry. 2025 Aug 27. doi: 10.1007/s00787-025-02837-z.
3
Efficacy and safety of 3CL protease inhibitors in patients with mild or moderate COVID-19: a systematic review and meta-analysis of randomized controlled trials.3CL蛋白酶抑制剂治疗轻中度新型冠状病毒肺炎患者的疗效和安全性：一项随机对照试验的系统评价和Meta分析
Virol J. 2025 Aug 21;22(1):286. doi: 10.1186/s12985-025-02899-0.
4
Changes in the pulmonary surfactant in patients with mild to moderate COVID-19.轻度至中度新型冠状病毒肺炎患者肺表面活性物质的变化
PLoS One. 2025 Aug 7;20(8):e0325153. doi: 10.1371/journal.pone.0325153. eCollection 2025.
5
Dysregulated type I/III interferon system in circulation from patients with anti-MDA5-positive dermatomyositis.抗MDA5阳性皮肌炎患者循环中I/III型干扰素系统失调。
Sci Rep. 2025 Jul 15;15(1):25537. doi: 10.1038/s41598-025-10895-1.
6
Clinical impacts of COVID-19 on severe exacerbation and mortality in interstitial lung disease: prognosis 30 days after infection.新型冠状病毒肺炎对间质性肺疾病严重加重和死亡率的临床影响：感染后30天的预后
Korean J Intern Med. 2025 Jul;40(4):634-644. doi: 10.3904/kjim.2024.388. Epub 2025 Jul 1.
7
The Impact of Hypoalbuminemia on Inflammatory Markers, Serum Creatinine, Hemoglobin and Outcome in Critically ill Patients With COVID-19 Infection-Retrospective Observation Study.低白蛋白血症对新型冠状病毒肺炎重症患者炎症标志物、血清肌酐、血红蛋白及预后的影响——回顾性观察研究
Acta Inform Med. 2025;33(2):96-100. doi: 10.5455/aim.2025.33.96-100.
8
A novel approach to estimating through infection networks: understanding regional transmission dynamics of COVID-19.一种通过感染网络进行估算的新方法：了解新冠病毒病的区域传播动态
Front Public Health. 2025 Jun 18;13:1586786. doi: 10.3389/fpubh.2025.1586786. eCollection 2025.
9
Multiomics analyses of gut microbiota and metabolites in people living with HIV before and during SARS-COV-2 infection.HIV感染者在感染SARS-CoV-2之前及期间肠道微生物群和代谢物的多组学分析。
Sci Rep. 2025 Jul 1;15(1):22144. doi: 10.1038/s41598-025-06815-y.
10
Bacteriome Signature in SARS-CoV-2-Infected Patients Correlates with Increased Gut Permeability and Systemic Inflammatory Cytokines.新冠病毒感染患者的细菌群落特征与肠道通透性增加和全身炎症细胞因子相关。
Microorganisms. 2025 Jun 16;13(6):1407. doi: 10.3390/microorganisms13061407.
Zotero 插件